Group items tagged

"Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles" presents the use of endpoints or outcomes measures in respiratory disease's clinical trials. In this report, endpoint used in asthma, cystic fibrosis, chronic obstructive pulmonary disorder and pulmonary arterial hypertension are presented. In this report detailed analysis about the clinical and surrogate endpoint used in various phases and stages of clinical trials are presented. This report presents detailed overview about the endpoint used in major marketed drugs and most promising molecules under development. The report contains company profiles of major companies involved with marketing of major marketed drugs under respiratory drug franchise.

ACCESS REPORT : Polypoidal Choroidal Vasculopathy Clinical Trials Review Global Research report 2015 GlobalData's clinical trial report, "Polypoidal Choroidal Vasculopathy Global Clinical Trials Review, H2, 2015″ provides an overview of Polypoidal Choroidal Vasculopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Polypoidal Choroidal Vasculopathy.

ACCESS REPORT : Corneal Neovascularization Clinical Trials Review Global Research report 2015 GlobalData's clinical trial report, "Corneal Neovascularization Global Clinical Trials Review, H2, 2015″ provides an overview of Corneal Neovascularization clinical trials scenario. This report provides top line data relating to the clinical trials on Corneal Neovascularization.

Pseudoexfoliation Syndrome Clinical Trials Review Global Research report2015 GlobalData's clinical trial report, "Pseudoexfoliation Syndrome Global Clinical Trials Review, H2, 2015″ provides an overview of Pseudoexfoliation Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Pseudoexfoliation Syndrome.

The European non-clinical information system report defines and segments the concerned market in Europe with analysis and forecast of revenue. The non-clinical information system market in Europe was valued at $2,490.3 million in 2013, and is estimated to grow to around $3,376.2 million by 2018, at a CAGR of 6.3% from 2013 to 2018.

The European non-clinical information system report defines and segments the concerned market in Europe with analysis and forecast of revenue. The non-clinical information system market in Europe was valued at $2,490.3 million in 2013, and is estimated to grow to around $3,376.2 million by 2018, at a CAGR of 6.3% from 2013 to 2018.

Summary "Down Syndrome Global Clinical Trials Review, H2, 2015″ provides an overview of Down Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Down Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

Summary "Hemochromatosis Global Clinical Trials Review, H2, 2015″ provides an overview of Hemochromatosis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemochromatosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

Summary "Primary Immune Deficiency (PID) Global Clinical Trials Review, H2, 2015″ provides an overview of Primary Immune Deficiency (PID) clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Immune Deficiency (PID). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

Summary "Neurofibromatoses Type I (Von Recklinghausen's Disease) Global Clinical Trials Review, H2, 2015″ provides an overview of Neurofibromatoses Type I (Von Recklinghausen's Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Neurofibromatoses Type I (Von Recklinghausen's Disease).

Billion people in India and more than a home for different life threatening diseases. These factors allow physicians and therapists worldwide to consider India as a destination for effective and clinical research studies. India has experienced rapid growth in the number of clinical trials in recent years, reflecting the fact that the country has become one of the most attractive destinations for medical research.

This reports provides most granular segmentation on Chromatography, E-Clinical Trial Solutions, Wireless Health and Clinical Trial Management Systems (CTMS). Technologies of this market are Microfluidics and Chromatography Reagents. Products of this market are Lab-on-chips (Microfluidics), Microreactors, Inotuzumab Ozogamicin and Marqibo. http://tinyurl.com/px6baxt

Mass Spectroscopy for Clinical Laboratory Analysis technique used in determining the basic composition and structure of a sample or molecule. The process involves bending a charged beam of vaporized material using an electric and/or magnetic field and then plotting a spectrum of how the sample's ions are deflected.

Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020

Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020 is a market research report available at US $4650 for a Single User PDF License from RnR Market Research Reports Library.

World Transfer Membrane Market is projected to achieve USD 187.9 million by 2023, at a CAGR of 1.5%. The most important share of this section is attributed to rising incidence of disease, allergy, and infectious diseases and siginifcant application of western blotting in clinical identification & post-treatment watching of those diseases.

This report provides a comprehensive review and update of biomarkers of breast cancer. Recent years have seen the discovery of a large number of new biomarkers and clinical data are now available on previously discovered markers is not yet in common use. Together these provide information, diagnosis and treatment in key areas of breast cancer.

Flow cytometry is a laboratory analytical technique that can rapidly measure multiple parameters of individual cells or particles as they pass through a beam of light, typically a laser. The global flow cytometry market remains one of the fastest-growing segments of life sciences and clinical diagnostics markets.